Open Access
Instituto superior de ci ncias da sa⁄de
Egas Moniz
- 01 Jan 2014
TL;DR: The regulation of feeding behavior also involves the monoamines dopamine, noradrenalin and serotonin involved in the reward center, a system that values the intake by the feeling of pleasure, and the endocannabinoid system that protects from anxiety and stimulates feeding.
read more
Abstract: 5 Abstract Feeding behavior depends on the balance between food intake and energy expenditure. This regulation occurs in the brain where the hypothalamus plays a key role. The hypothalamus receives adiposity signals by insulin and leptin that gives information about the state of energy reserves. When their levels are low, hypothalamus nuclei send signals through the orexigenic neuropeptides NPY, AgRP, CRH and orexins and ghrelin, a peripheral peptide that stimulate food intake. During ingestion, the first signals received by the brain are the pleasure channeled through the reward system, and the distension of the stomach that is communicated to the brainstem via the vagus nerve. Digestion causes the release of hormones that act as peripheral satiety signals, operating in the brainstem or in the arcuate nucleus (ARC) of the hypothalamus. Examples of such hormones are amylin, pancreatic polypeptide (PP), oxyntomodulin (OXM), cholecystokinin (CCK), glucagon-related peptide (GLP1) and peptide YY (PYY). The regulation of feeding behavior also involves the monoamines dopamine, noradrenalin and serotonin involved in the reward center, a system that values the intake by the feeling of pleasure, and the endocannabinoid system that protects from anxiety and stimulates feeding. Actually, there are few alternative drugs to treat obesity that are effective and safe because the pathways involved in feeding behavior are often easily compensated by other pathways, and are involved in the regulation of other systems.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
•Journal Article
BRIEF COMMUNICATION ARISING: Gut hormone PYY3-36 physiologically inhibits food intake
Rachel L. Batterham,Michael A. Cowley,Caroline J. Small,Herbert Herzog,Mark A Cohen,C. L. Dakin,Alison M. Wren,Audrey E. Brynes,Malcolm J. Low +8 more
TL;DR: The authors showed that post-prandial elevation of PYY3-36 may act through the arcuate nucleus Y2R to inhibit feeding in a gut-hypothalamic pathway.
1.9K
•Journal Article
MDS Clinical Diagnostic Criteria for Parkinson's Disease (S19.001)
Ronald B. Postuma,Daniela Berg +1 more
TL;DR: The International Parkinson and Movement Disorder Society (MDS) Clinical Diagnostic Criteria for Parkinson9s disease as discussed by the authors have been proposed for clinical diagnosis, which are intended for use in clinical research, but may also be used to guide clinical diagnosis.
1.6K
•Journal Article
Association of cocaine- and amphetamine-regulated transcript-immunoreactive elements with thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and its role in the regulation of the hypothalamic-pituitary-thyroid axis during fasting
Csaba Fekete,Emese Mihály,Lu Guang Luo,Joseph Kelly,Jes Thorn Clausen,Quan Fu Mao,William M. Rand,Larry G. Moss,Michael J. Kuhar,Charles H. Emerson,Ivor M. D. Jackson,Ronald M. Lechan +11 more
TL;DR: In this paper, triple-labeling fluorescent in situ hybridization and immunofluorescence were performed to reveal the morphological relationships between pro-TRH mRNA-containing neurons and CART- and alpha-MSH-immunoreactive (IR) axons.
151
Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects
Erik Näslund,Neil A. King,S. Mansten,N. Adner,Jens J. Holst,M. K. Gutniak,Per M. Hellström +6 more
- 01 Jan 2004
TL;DR: In this article, a 5-day infusion of recombinant glucagon-like peptide-1 (7-36)amide (rGLP-1) was shown to cause significant weight loss in type 2 diabetics when administered for 6 weeks as a continuous subcutaneous infusion.
149
References
Outpatient Treatment of 'Crack' Cocaine Smoking With Flupenthixol Decanoate: A Preliminary Report
TL;DR: Promising but preliminary data, combined with the magnitude of problems presented by crack, warrant rapid, expanded double-blind assessment of flupenthixol decanoate in cocaine-abuse treatment.
127
Comparison of periodontal and peri‐implant probing by depth‐force pattern analysis
TL;DR: It is concluded that peri-implant probing depth measurements are more sensitive to force variation than periodontal pocket probing.
127
Transglutaminase Inhibition by 2-[(2-Oxopropyl)thio]imidazolium Derivatives: Mechanism of Factor XIIIa Inactivation
Kurt Freund,Kundan P. Doshi,Stanley L. Gaul,David A. Claremon,Remy David C,Baldwin John J,Steven M. Pitzenberger,Andrew M. Stern +7 more
TL;DR: The physiologic role of several transglutaminases could be more precisely defined with the development of specific inhibitors for these enzymes with therapeutic utility in the treatment of thrombosis and the observed enhancements in clot lysis rates were studied.
127
•Journal Article
Canine impactions: incidence and management.
Jason Cooke,Hom-Lay Wang +1 more
TL;DR: The incidence and etiology associated with impacted maxillary canines, the clinical and radiographic evaluation of the situation, and the techniques for managing this problem are addressed.
127
A Comparison of Coronal Tooth Discoloration Elicited by Various Endodontic Reparative Materials
Louis J. Marconyak,Timothy C. Kirkpatrick,Howard W. Roberts,Mark D. Roberts,Arnau Aparicio,Van T. Himel,Kent A. Sabey +6 more
TL;DR: EndoSequence Root Repair Material and Biodentine produced significantly less discoloration than white Pro Root MTA, MTA Angelus, and ProRoot MTA when used in an ex vivo pulpotomy model.
127